4//SEC Filing
Bowden Christopher 4
Accession 0000899243-22-023978
CIK 0001107421other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:31 PM ET
Size
6.9 KB
Accession
0000899243-22-023978
Insider Transaction Report
Form 4
Bowden Christopher
Director
Transactions
- Award
Common Stock
2022-06-22+40,000→ 44,167 total - Award
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 totalExercise: $0.82Exp: 2032-06-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests in twelve equal monthly installments beginning on July 13, 2022.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001608601
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:31 PM ET
- Size
- 6.9 KB